Clicky

Semler Scientific, Inc.(SMLR)

Description: Semler Scientific, Inc. develops, manufactures and markets products and services that assist healthcare insurers and physician groups in evaluating and treating chronic diseases. The Company markets QuantaFlo and WellChec to its customers. QuantaFlo is an approximately four-minute in-office blood flow test. The routine office usage of the QuantaFlo has ranges from few tests per week to over 10 tests per day. The Company also offers contracts in which it invoices on a per test basis for use of QuantaFlo, or as part of the WellChec multi-test platform. WellChec is the Company's multi-test service platform. WellChec provides testing equipment and third-party personnel to perform tests and examinations of patients for the Company's customers. The tests performed are for chronic disease states, which include respiratory disease, vascular disease, eye disease, bone disease, heart disease, neuropathy and diabetes.


Keywords: Medicine Disease Diabetes Organ Systems Cardiovascular Disease Disability Chronic Disease Respiratory Diseases Vascular Disease Heart Disease Eye Diseases Peripheral Neuropathy Testing Equipment Bone Disease Healthcare Insurers

Home Page: www.semlerscientific.com

SMLR Technical Analysis

2340-2348 Walsh Avenue
Santa Clara, CA 95051
United States
Phone: 877 774 4211


Officers

Name Title
Dr. Douglas Murphy-Chutorian M.D. CEO, Corp. Sec. & Director
Mr. Andrew B. Weinstein Sr. VP of Fin. & Accounting
Dr. Herbert J. Semler Founder & Chairman Emeritus
Mr. Robert G. McRae Chief Technical Officer
Mr. Dennis Rosenberg Chief Marketing Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 24.7403
Price-to-Book MRQ: 4.5951
Price-to-Sales TTM: 4.2347
IPO Date: 2014-02-21
Fiscal Year End: December
Full Time Employees: 124
Back to stocks